Comparison of rosuvastatin and atorvastatin on clopidogrel response and lipidic and inflammatory parameters after coronary stenting for acute coronary syndrome: the prospective, randomized OSCAR study (optimal statin therapy with clopidogrel after coronary revascularisation)

Thromb Res. 2010 Nov;126(5):e397-9. doi: 10.1016/j.thromres.2010.08.005. Epub 2010 Sep 9.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Acute Coronary Syndrome / blood
  • Acute Coronary Syndrome / drug therapy*
  • Acute Coronary Syndrome / surgery*
  • Anticholesteremic Agents / therapeutic use
  • Atorvastatin
  • Clopidogrel
  • Combined Modality Therapy
  • Cytochrome P-450 CYP3A / metabolism
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Fluorobenzenes / therapeutic use*
  • Heptanoic Acids / therapeutic use*
  • Humans
  • Platelet Aggregation / drug effects
  • Platelet Aggregation Inhibitors / therapeutic use
  • Prospective Studies
  • Pyrimidines / therapeutic use*
  • Pyrroles / therapeutic use*
  • Rosuvastatin Calcium
  • Stents*
  • Sulfonamides / therapeutic use*
  • Ticlopidine / analogs & derivatives*
  • Ticlopidine / therapeutic use

Substances

  • Anticholesteremic Agents
  • Fluorobenzenes
  • Heptanoic Acids
  • Platelet Aggregation Inhibitors
  • Pyrimidines
  • Pyrroles
  • Sulfonamides
  • Rosuvastatin Calcium
  • Atorvastatin
  • Clopidogrel
  • Cytochrome P-450 CYP3A
  • CYP3A4 protein, human
  • Ticlopidine